Literature DB >> 30481782

Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.

Xia Zheng1,2, Yuanyuan Zhou1,2, Wei Chen3, Lihong Chen4, Jiaojiao Lu1,2, Fang He1,2, Xu Li1,2, Le Zhao5,6.   

Abstract

BACKGROUND/AIMS: The Warburg effect is one of the main metabolic features for cancers, with long non-coding RNA (lncRNA) being involved as a class of crucial regulators. Our previous studies have shown that ginsenoside 20(S)-Rg3, an active saponin monomer extracted from red ginseng, inhibits the Warburg effect in ovarian cancer cells. However, the detailed lncRNA regulatory network modulated by 20(S)-Rg3 to prevent the Warburg effect in ovarian cancer cells has not been explored.
METHODS: High-throughput sequencing was used to screen out the differentially expressed lncRNAs between 20(S)-Rg3-treated and non-treated SKOV3 cells. The levels of lncRNA H19 and miR-324-5p were manipulated in SKOV3 and A2780, and the glucose consumption, lactate production and PKM2 protein level were detected. Dual-luciferase reporter assay and RIP were utilized to verify the direct binding of H19 to miR-324-5p and miR-324-5p to PKM2. Cell proliferation was examined by CCK8 and colony formation assay. Nude mice subcutaneous xenograft tumor models were established to evaluate the impact of miR-324-5p on tumor growth in vivo.
RESULTS: 20(S)-Rg3 downregulated 67 lncRNAs, and H19 was one of the most decreased lncRNAs. Suppression of H19 by siRNA transfection reduced glucose consumption, lactate production and PKM2 expression in ovarian cancer cells, while H19 overexpression in 20(S)-Rg3-treated ovarian cancer cells enhanced glucose consumption, lactate production and PKM2 expression. Dual-luciferase reporter assay and RIP results showed that H19 directly bound to miR-324-5p. Dual-luciferase reporter assay showed that miR-324-5p directly targeted PKM2, and miR-324-5p negatively regulated glucose consumption and lactate production in ovarian cancer cells. miR-324-5p overexpression inhibited cell proliferation in vitro and in vivo.
CONCLUSION: Our study revealed that 20(S)-Rg3 blocked the competitive inhibition of H19 on miR-324-5p, which enhanced the suppression of miR-324-5p on PKM2 and therefore inhibited the Warburg effect and repressed tumorigenesis. In a word, 20(S)-Rg3 inhibited the Warburg effect in ovarian cancer cells via H19/miR-324-5p/PKM2 pathway.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Ginsenoside; Long non-coding RNA; Ovarian cancer; Warburg effect

Mesh:

Substances:

Year:  2018        PMID: 30481782     DOI: 10.1159/000495552

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  21 in total

Review 1.  Pyruvate kinase M2: A simple molecule with complex functions.

Authors:  Mohammed Alquraishi; Dexter L Puckett; Dina S Alani; Amal S Humidat; Victoria D Frankel; Dallas R Donohoe; Jay Whelan; Ahmed Bettaieb
Journal:  Free Radic Biol Med       Date:  2019-08-08       Impact factor: 7.376

Review 2.  Insights into the antitumor mechanism of ginsenosides Rg3.

Authors:  Zongyu Liu; Tongjun Liu; Wei Li; Jiannan Li; Cuizhu Wang; Kai Zhang
Journal:  Mol Biol Rep       Date:  2021-03-04       Impact factor: 2.316

Review 3.  The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.

Authors:  Dexter L Puckett; Mohammed Alquraishi; Winyoo Chowanadisai; Ahmed Bettaieb
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

4.  [Ginsenoside 20(S)-Rg3 upregulates tumor suppressor VHL gene expression by suppressing DNMT3A-mediated promoter methylation in ovarian cancer cells].

Authors:  Lijie Wang; Xi Han; Xia Zheng; Yuanyuan Zhou; Huilian Hou; Wei Chen; Xu Li; Le Zhao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

5.  Resibufogenin suppresses tumor growth and Warburg effect through regulating miR-143-3p/HK2 axis in breast cancer.

Authors:  Ying Guo; Fei Liang; Fuli Zhao; Jian Zhao
Journal:  Mol Cell Biochem       Date:  2020-01-31       Impact factor: 3.842

Review 6.  Long non-coding RNA H19, a novel therapeutic target for pancreatic cancer.

Authors:  Jing Wang; Lei Zhao; Kun Shang; Fang Liu; Juanjuan Che; Huihui Li; Bangwei Cao
Journal:  Mol Med       Date:  2020-04-09       Impact factor: 6.354

Review 7.  The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use.

Authors:  Martín Salamini-Montemurri; Mónica Lamas-Maceiras; Aida Barreiro-Alonso; Ángel Vizoso-Vázquez; Esther Rodríguez-Belmonte; María Quindós-Varela; María Esperanza Cerdán
Journal:  Cancers (Basel)       Date:  2020-04-21       Impact factor: 6.639

Review 8.  Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Authors:  Alexandru A Sabo; Maria Dudau; George L Constantin; Tudor C Pop; Christoph-M Geilfus; Alessio Naccarati; Mihnea P Dragomir
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

Review 9.  Antitumor effects and molecular mechanisms of action of natural products in ovarian cancer.

Authors:  Yun-Bo Yan; Qing Tian; Ji-Fang Zhang; Ying Xiang
Journal:  Oncol Lett       Date:  2020-08-20       Impact factor: 2.967

Review 10.  The role of long non-coding RNA H19 in breast cancer.

Authors:  Ji Wang; Jinyu Sun; Fen Yang
Journal:  Oncol Lett       Date:  2019-11-14       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.